Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Finished Goods: 2019-2020

  • Sunshine Biopharma's Finished Goods rose 49.41% to $23,771 in Q4 2020 from the same period last year, while for Dec 2020 it was $23,771, marking a year-over-year increase of 49.41%. This contributed to the annual value of $23,771 for FY2020, which is 49.41% up from last year.
  • As of Q4 2020, Sunshine Biopharma's Finished Goods stood at $23,771, which was up 49.41% from $15,910 recorded in Q4 2019.
  • Over the past 5 years, Sunshine Biopharma's Finished Goods peaked at $23,771 during Q4 2020, and registered a low of $15,910 during Q4 2019.
  • Over the past 2 years, Sunshine Biopharma's median Finished Goods value was $19,840 (recorded in 2019), while the average stood at $19,840.
  • Data for Sunshine Biopharma's Finished Goods shows a peak YoY soared of 49.41% (in 2020) over the last 5 years.
  • Quarterly analysis of 2 years shows Sunshine Biopharma's Finished Goods stood at $15,910 in 2019, then surged by 49.41% to $23,771 in 2020.